Conference Coverage
Conference Coverage
Tricks for treating C. diff in IBD
If your patient with irritable bowel disease is infected with Clostridium difficile, should you discontinue immunosuppression? How safe are fecal...
Conference Coverage
New regimen for hepatitis C genotype 2 beats previous standard of care
A two-drug regimen without ribavirin was found superior to the current standard of care for genotype 2 (GT2) hepatitis C virus infection,...
Conference Coverage
Early infection-related hospitalization portends poor breast cancer prognosis
Particularly close monitoring for adverse breast cancer outcomes is warranted for women with an infection-related hospitalization during the first...
Conference Coverage
IDWEEK: Cefazolin beats ceftriaxone for MSSA bacteremia treatment
Veteran patients treated with ceftriaxone for methicillin-susceptible Staphylococcus aureus bacteremia were more likely to have treatment failure...
Conference Coverage
AAP: Histories key to differentiating recurrent and periodic fevers
Dr. Kathryn M. Edwards tells how understanding a child’s fever history and other symptoms is key to determining what is causing the fever and what...
Conference Coverage
ACC/AHA risk estimator underpredicts in HIV+ individuals
The 2013 ACC/AHA risk estimator needs a tune-up before it can be reliably applied to HIV-infected adults.
Conference Coverage
ACR: Don’t be fooled by contaminated synovial fluid
Hold off on surgery in patients with presumed septic arthritis if they’re not otherwise too sick and their cultures don’t grow out a pathogenic...
Conference Coverage
Global HIV treatment goals face resource challenges
The World Health Organization’s treatment targets for HIV may be financially unachievable, according to modeling that predicts a potential...
Conference Coverage
Proportion of HCV patients in U.S. with cirrhosis climbing
Key clinical point: Despite a national decline in the prevalence of hepatitis C virus infection, the prevalence of cirrhosis among HCV-infected...
Conference Coverage
ARC-520 shows promise in chronic hepatitis B
ARC-520, the first RNA interference–based drug to reach patients, produced deep and durable knockdown of viral antigens and DNA in chronic...
Conference Coverage
ACR: Don’t give pneumococcal vaccine to CAPS, Behçet’s patients
Pneumococcal vaccines can trigger severe local and systemic inflammatory reactions in patients with cryopyrin-associated periodic syndromes,...